COVID-19

In this COVID-19 pandemic, Veredus has available resources to support you with meeting demands for clinical testing. Starting from viral RNA extraction to molecular assay for the detection of SARS-CoV-2, we introduce a comprehensive diagnostic solution. Alternatively, we can also support you with rapid detection using serological testing.  Bookmark this page for updates as we learn more about COVID-19, its impact and how Veredus can continue supporting you as the crisis continues.

Request a quotation today

 

 

Rapid Antibody Test

 

Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19

This is a rapid serological test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2 in human whole blood, serum or plasma, capable of providing test results as fast as 10 minutes to support triage and clinical decision.

  • Received Singapore Health Sciences Authority provisional authorization for In vitro Diagnostic (IVD) use in Singapore.
  • Available as CE-IVD.

Download the brochure on the Rapid Antibody Test

 

Molecular Tests

 

  • VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 
  • VereRTCoV™ 3.0 ZeroStep Real-Time RT-PCR
  • VereCoV™ Detection Kit for VerePLEX™ Biosystem

 

VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 

This is a one-step Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In vitro Diagnostic (IVD) test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2.

  • Detects the Dual viral N gene targets (FAM detection channel) and endogenous human RPP30 gene as the Human Internal Control (HEX detection channel) within the assay in a qPCR cycler.
  • Dual N gene targets (FAM) provides enhanced tolerance against gene mutations.
  • Tested compatible for use with Applied Biosystem®️ 7500 Real-Time PCR System and Biorad™ CFX96 Touch Real-Time PCR Detection System.
  • Received Provisional Authorisation for In vitro Diagnostic (IVD) use in Singapore by Health Sciences Authority (HSA) Singapore.
  • CE-IVD
  • Philippines FDA approved

Download the brochure on VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0
Download the brochure on VereRTCoV™ 3.0 ZeroStep Real-Time RT-PCR

VereCoV™ Detection Kit

This is a portable Lab-On-Chip assay test combining both multiplexing PCR and microarray technologies that is able to identify and differentiate SARS-CoV and SARS-CoV-2 within a single test on the VerePLEX™ Biosystem.

  • Received Singapore Health Sciences Authority provisional authorization for In vitro Diagnostic (IVD) use in Singapore.
  • Available as CE-IVD.

As part of Singapore’s efforts to control and minimise the spread of COVID-19 amongst populations, the government established laboratory testing capabilities which made it mandatory for travellers at checkpoints coming into Singapore with clinical symptoms of respiratory illness and/or fever to provide nasal swab specimens for testing using VereCoV™ Detection Kit. Consequently, the government reported several imported cases of COVID-19 and containment actions were implemented swiftly.

Read the full story:

Channel News Asia – New COVID-19 test kits used to screen swab samples collected at Singapore checkpoints

Today – New COVID-19 test kit deployed at all Singapore checkpoints detects its first imported case

Watch the news commentary:

 

Request a quotation now